-+ 0.00%
-+ 0.00%
-+ 0.00%
Profarma Reports Q3 Net Debt of R$ 1.4 Billion
Share
Listen to the news
Profarma Reports Q3 Net Debt of R$ 1.4 Billion
  • Profarma ended third-quarter 2026 with total net debt of R$ 1.4 billion, including R$ 537.2 million in 4BIO acquisition obligations.
  • Net bank debt fell to R$ 827.7 million from R$ 893.1 million in the second quarter.
  • Leverage including 4BIO stood at 2.8 times adjusted EBITDA; excluding the business, it declined to 1.8 times from 2.2 times.
  • An October debenture issuance raised R$ 300 million to extend debt maturities, with a five-year term at CDI plus 1.45% annually.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Profarma Distribuidora de Produtos Farmacêuticos SA published the original content used to generate this news brief on November 12, 2026, and is solely responsible for the information contained therein.

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.
What's Trending